SCA
BMY icon

Salient Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Salient Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-7,750
Closed -$432K – 74
2017
Q2 		$432K Sell
7,750
-65
-0.8% -$3.54K 0.01% 161
2017
Q1 		$425K Buy
7,815
+450
+6% +$24.7K 0.01% 194
2016
Q4 		$430K Sell
7,365
-847
-10% -$46.3K 0.01% 191
2016
Q3 		$443K Buy
8,212
+252
+3% +$16.2K 0.01% 171
2016
Q2 		$585K Sell
7,960
-173
-2% -$12.2K 0.01% 159
2016
Q1 		$520K Sell
8,133
-3,640
-31% -$230K 0.01% 168
2015
Q4 		$810K Sell
11,773
-1,690
-13% -$112K 0.02% 134
2015
Q3 		$797K Sell
13,463
-607
-4% -$38.5K 0.02% 142
2015
Q2 		$936K Sell
14,070
-20
-0.1% -$1.32K 0.02% 145
2015
Q1 		$909K Sell
14,090
-1,040
-7% -$65.1K 0.02% 142
2014
Q4 		$893K Buy
15,130
+1,548
+11% +$87.3K 0.02% 160
2014
Q3 		$695K Sell
13,582
-223
-2% -$11.1K 0.01% 164
2014
Q2 		$670K Sell
13,805
-520
-4% -$25.6K 0.01% 159
2014
Q1 		$744K Sell
14,325
-24,970
-64% -$1.33M 0.02% 154
2013
Q4 		$2.09M Buy
39,295
+320
+0.8% +$16.3K 0.07% 88
2013
Q3 		$1.8M Buy
38,975
+1,222
+3% +$53.6K 0.08% 85
2013
Q2 		$1.69M Buy
+37,753
New +$1.64M 0.08% 84

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Salient Capital Advisors's BMY Position: Q3 2017 in Review

Salient Capital Advisors sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 7,750 shares — an estimated $432K sold.

Salient Capital Advisors first reported a position in BMY in Q2 2013 and held it in 17 quarters. The position peaked at $2.09M in Q4 2013. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

  • Salient Capital Advisors reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
  • Salient Capital Advisors sold 7,750 Bristol-Myers Squibb shares in Q3 2017, an estimated $432K.
  • Salient Capital Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 17 quarters.
  • Salient Capital Advisors's Bristol-Myers Squibb position peaked at $2.09M in Q4 2013.
  • 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on Salient Capital Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.